Julius Melnitzer

Julius Melnitzer

November 30, 2010 | Corporate Counsel

Antitrust Laws Gain Momentum In Asia Pacific

An economic boom in the Asia Pacific is leading to more antitrust and competition laws.

By Julius Melnitzer

18 minute read

October 31, 2010 | Corporate Counsel

Pharmaceutical Company Abuses Dominant Market Position To Block Competition

A European court's decision could affect conduct in other industries that involve patents.

By Julius Melnitzer

6 minute read

September 30, 2010 | Corporate Counsel

Canada's Federal Court of Appeal Offers Some Guidance on Transfer Pricing Issues

GlaxoSmithKline decision establishes that courts determining appropriate transfer prices must consider business realities.

By Julius Melnitzer

12 minute read

August 19, 2010 | Corporate Counsel

Federal Court of Canada Holds Foreign Investors to Their Promises

U.S. Steel sued for failing to comply with the Investment Canada Act.

By Julius Melnitzer

13 minute read

July 31, 2010 | Corporate Counsel

Canadian Supreme Court shortens time to collect foreign arbitration awards

Ruling makes it tough to enforce awards.

By Julius Melnitzer

16 minute read

July 31, 2010 | Corporate Counsel

Canadian Supreme Court Limits Collection of Arbitration Awards

Yugraneft v. Rexx Management Corporation ruling could alter Canada's arbitration-friendly reputation.

By Julius Melnitzer

16 minute read

June 30, 2010 | Corporate Counsel

New U.K. Bribery Act Creates More Pitfalls for Companies

The act reaches further than the FCPA.

By Julius Melnitzer

16 minute read

May 31, 2010 | Corporate Counsel

China Addresses Privacy in New Law

It's the country's first piece of legislation to affect personal data.

By Julius Melnitzer

3 minute read

May 31, 2010 | Corporate Counsel

China's New Tort Law Raises Questions in an Uncertain Civil Landscape

But in addition to new questions, it offers some guidance.

By Julius Melnitzer

6 minute read

April 30, 2010 | Corporate Counsel

Euronext Cross-Listing Offers Benefits to U.S. Companies

U.S.-listed public companies may benefit from cross-listing in the eurozone.

By Julius Melnitzer

25 minute read